Literature DB >> 5330780

Double-blind trial of the treatment of episcleritis-scleritis with oxyphenbutazone or prednisolone.

P G Watson, D J Lobascher, D W Sabiston, E Lewis-Faning, P D Fowler, B R Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5330780      PMCID： PMC506254          DOI： 10.1136/bjo.50.8.463

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  MEASUREMENT OF SERUM URIC ACID IN GREAT BRITAIN IN 1963.

Authors:  E G BYWATERS; V P HOLLOWAY
Journal:  Ann Rheum Dis       Date:  1964-05       Impact factor: 19.103

2.  Hydroxyphenylbutazone in the treatment of nodular scleritis.

Authors:  S K BANNERJEE; P TAYLOR
Journal:  Trans Ophthalmol Soc U K       Date:  1961

3.  A series of cases treated locally by cortisone; a preliminary report to the Medical Council by the panel on the ophthalmological applications of cortisone and ACTH.

Authors:  S DUKE-ELDER; O M DUTHIE; J FOSTER; F W LAW; A LISTER; A MCKIE REID; G I SCOTT; E C ZORAB; A J B GOLDSMITH
Journal:  Br J Ophthalmol       Date:  1951-11       Impact factor: 4.638

4.  Scleromalacia; clinical and pathologic study of a case with consideration of differential diagnosis, relationship of collagen disease, and effect of ACTH and cortisone therapy.

Authors:  B ANDERSON; G MARGOLIS
Journal:  Am J Ophthalmol       Date:  1952-07       Impact factor: 5.258

5.  Hydroxy-phenylbutazone (Tanderil) in the treatment of ocular disease. A preliminary survey.

Authors:  L E WERNER
Journal:  Br J Ophthalmol       Date:  1960-12       Impact factor: 4.638
  5 in total
  6 in total

1.  Treatment of episcleritis. A double-blind trial comparing betamethasone 0.1 per cent, oxyphenbutazone 10 per cent, and placebo eye ointments.

Authors:  P G Watson; D A McKay; R S Clemett; P Wilkinson
Journal:  Br J Ophthalmol       Date:  1973-11       Impact factor: 4.638

2.  Necrogranulomatous scleritis treated by an onlay scleral graft.

Authors:  D Sevel; A Abramson
Journal:  Br J Ophthalmol       Date:  1972-11       Impact factor: 4.638

3.  Prednisolone-21-stearoylglycolate in scleritis.

Authors:  S S Hayreh; P G Watson
Journal:  Br J Ophthalmol       Date:  1970-06       Impact factor: 4.638

4.  Scleritis and temporal arteritis.

Authors:  R G Long; A I Friedmann; D G James
Journal:  Postgrad Med J       Date:  1976-11       Impact factor: 2.401

5.  Scleritis and episcleritis.

Authors:  P G Watson; S S Hayreh
Journal:  Br J Ophthalmol       Date:  1976-03       Impact factor: 4.638

6.  Prostaglandins, nonsteroidal anti-inflammatory agents and eye disease.

Authors:  S M Podos
Journal:  Trans Am Ophthalmol Soc       Date:  1976
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.